Symptomatic Parainfluenza Virus Infections in Children Undergoing Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 10, 2011, Pages 1520-1527

  Srinivasan, Ashok ^a,b   Wang, Chong ^a   Yang, Jie ^a   Shenep, Jerry L ^a,b   Leung, Wing H ^a,b   Hayden, Randall T ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Incidence; Mortality; Pneumonia; Risk factors

Indexed keywords

PALIVIZUMAB; RESPIRATORY SYNCYTIAL VIRUS ANTIBODY; RIBAVIRIN; STEROID;

ACUTE GRAFT VERSUS HOST DISEASE; AFRICAN AMERICAN; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ARTIFICIAL VENTILATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHILD; COHORT ANALYSIS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; LEUKOCYTE COUNT; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PARAINFLUENZA VIRUS INFECTION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RETROSPECTIVE STUDY; SCHOOL CHILD; SYMPTOMATIC PARAINFLUENZA VIRUS INFECTION; THORAX RADIOGRAPHY; VIRAL UPPER RESPIRATORY TRACT INFECTION; VIRUS SHEDDING; WHOLE BODY RADIATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE SYSTEM DISEASES; MALE; METABOLIC DISEASES; NEOPLASMS; PARAMYXOVIRIDAE INFECTIONS; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 80052962399     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.03.001     Document Type: Article

References (22)

1. Nichols W.G., Corey L., Gooley T., et al. Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. Blood 2001, 98:573-578.
2. Elizaga J., Olavarria E., Apperley J.F., et al. Parainfluenza virus 3 infection after stem cell transplant: relevance to outcome of rapid diagnosis and ribavirin treatment. Clin Infect Dis 2001, 32:413-418.
3. Lewis V.A., Champlin R., Englund J., et al. Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients. Clin Infect Dis 1996, 23:1033-1037.
4. Wendt C.H., Weisdorf D.J., Jordan M.C., et al. Parainfluenza virus respiratory infection after bone marrow transplantation. N Engl J Med 1992, 326:921-926.
5. Weinberg G.A., Hall C.B., Iwane M.K., et al. Parainfluenza virus infection of young children: estimates of the population-based burden of hospitalization. J Pediatr 2009, 154:694-699.
6. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995, 15:825-828.
7. Reed G., Jewett P.H., Thompson J., et al. Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children <5 years old. J Infect Dis 1997, 175:807-813.
8. Franquet T., Müller N.L., Giménez A., et al. Infectious pulmonary nodules in immunocompromised patients: usefulness of computed tomography in predicting their etiology. J Comput Assist Tomogr 2003, 27:461-468.
9. van Elden L.J., van Kraaij M.G., Nijhuis M., et al. Polymerase chain reaction is more sensitive than viral culture and antigen testing for the detection of respiratory viruses in adults with hematological cancer and pneumonia. Clin Infect Dis 2002, 34:177-183.
10. Weinberg A., Zamora M.R., Li S., et al. The value of polymerase chain reaction for the diagnosis of viral respiratory tract infections in lung transplant recipients. J Clin Virol 2002, 25:171-175.
11. Weshler Z., Breuer R., Or R., et al. Interstitial pneumonitis after total body irradiation: effect of partial lung shielding. Br J Haematol 1990, 74:61-64.
12. Chakrabarti S., Avivi I., Mackinnon S., et al. Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality. Br J Haematol 2002, 119:1125-1132.
13. Martino R., Porras R.P., Rabella N., et al. Prospective study of the incidence, clinical features and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Biol Blood Marrow Transplant 2005, 11:781-796.
14. Erard V., Chien J.W., Kim, et al. Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: the role of community respiratory viruses. J Infect Dis 2006, 193:1619-1625.
15. Peck A.J., Englund J.A., Kuypers J., et al. Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection. Blood 2007, 110:1681-1688.
16. Kapikian A.Z., Chanock R.M., Reichelderfer T.E., et al. Inoculation of human volunteers with parainfluenza virus type 3. JAMA 1961, 178:537-541.
17. Frank A.L., Taber L.H., Wells C.R., et al. Patterns of shedding of myxoviruses and paramyxoviruses in children. J Infect Dis 1981, 144:433-441.
18. Brady M.T., Evans J., Cuartas J. Survival and disinfection of parainfluenza viruses on environmental surfaces. Am J Infect Control 1990, 18:18-23.
19. Belshe R.B., Newman F.K., Anderson E.L., et al. Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children. J Infect Dis 2004, 190:2096-2103.
20. Slobod K., Shenep J., Lujan-Zilbermann J., et al. Safety and immunogenicity of intranasal murine parainfluenza virus type 1 (Sendai virus) in healthy human adults. Vaccine 2004, 22:3182-3186.
21. Hurwitz J. Development of recombinant Sendai virus vaccines for prevention of human parainfluenza and respiratory syncytial virus infections. Pediatr Infect Dis J 2008, 27(Suppl):S126-S128.
22. Peduzzi P., Concato J., Kemper E., et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996, 49:1373-1379.